Reference Source

I.I.C.H. Intern. Isotopes Clearing · 66-66 · GERMANY

For I.I.C.H. Intern. Isotopes Clearing · 66-66 · GERMANY, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is GERMANY; product is Doxorubicin; product code is 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Obergasse 4 , Volxheim, Rhineland-Palatinate GERMANY, verified against its source on 2026-09-16.

Firm
I.I.C.H. Intern. Isotopes Clearing verified
Import alert
66-66
Import alert name
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
Country
GERMANY verified
Address
Obergasse 4 , Volxheim, Rhineland-Palatinate GERMANY verified
Date published
09/30/2009 verified
Product code
56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf verified
Product
Doxorubicin verified
FDA notes
11/2/2000 verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

I.I.C.H. Intern. Isotopes Clearing Date Published : 09/30/2009 Obergasse 4 , Volxheim, Rhineland-Palatinate GERMANY 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Doxorubicin Notes: 11/2/2000

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.